Church & Dwight Co., Inc. (NYSE:CHD) Stock Holdings Lifted by Royal London Asset Management Ltd.

Royal London Asset Management Ltd. lifted its holdings in Church & Dwight Co., Inc. (NYSE:CHD - Free Report) by 4.6% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 466,144 shares of the company's stock after acquiring an additional 20,433 shares during the period. Royal London Asset Management Ltd. owned 0.19% of Church & Dwight worth $48,810,000 at the end of the most recent reporting period.

Several other hedge funds have also recently modified their holdings of CHD. YANKCOM Partnership bought a new stake in Church & Dwight during the fourth quarter worth approximately $25,000. Versant Capital Management Inc increased its position in shares of Church & Dwight by 224.4% during the fourth quarter. Versant Capital Management Inc now owns 266 shares of the company's stock worth $28,000 after acquiring an additional 184 shares during the period. Strategic Financial Concepts LLC purchased a new position in shares of Church & Dwight during the fourth quarter valued at $39,000. Bank of Jackson Hole Trust purchased a new position in Church & Dwight during the 4th quarter valued at about $43,000. Finally, Golden State Wealth Management LLC purchased a new stake in Church & Dwight during the fourth quarter worth $51,000. Hedge funds and other institutional investors own 86.60% of the company's stock.

Church & Dwight Price Performance

Shares of NYSE:CHD traded down $2.24 during trading on Tuesday, hitting $104.66. 1,083,981 shares of the stock were exchanged, compared to its average volume of 1,391,955. The company has a current ratio of 1.70, a quick ratio of 1.24 and a debt-to-equity ratio of 0.51. The company has a market cap of $25.74 billion, a PE ratio of 44.16, a P/E/G ratio of 3.32 and a beta of 0.57. Church & Dwight Co., Inc. has a 12-month low of $96.35 and a 12-month high of $116.46. The company has a fifty day moving average price of $107.50 and a two-hundred day moving average price of $105.89.

Remove Ads

Church & Dwight (NYSE:CHD - Get Free Report) last posted its quarterly earnings data on Friday, January 31st. The company reported $0.77 EPS for the quarter, hitting analysts' consensus estimates of $0.77. Church & Dwight had a return on equity of 20.03% and a net margin of 9.58%. During the same quarter in the previous year, the firm posted $0.65 earnings per share. On average, analysts forecast that Church & Dwight Co., Inc. will post 3.7 EPS for the current year.

Church & Dwight Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, March 3rd. Stockholders of record on Friday, February 14th were given a dividend of $0.295 per share. This represents a $1.18 dividend on an annualized basis and a dividend yield of 1.13%. This is a positive change from Church & Dwight's previous quarterly dividend of $0.28. The ex-dividend date was Friday, February 14th. Church & Dwight's payout ratio is presently 49.79%.

Wall Street Analyst Weigh In

A number of analysts have recently weighed in on the stock. JPMorgan Chase & Co. lowered their price target on shares of Church & Dwight from $107.00 to $106.00 and set an "underweight" rating on the stock in a report on Friday, February 21st. Royal Bank of Canada restated a "sector perform" rating and issued a $105.00 target price on shares of Church & Dwight in a research note on Monday, February 3rd. Barclays boosted their target price on shares of Church & Dwight from $90.00 to $93.00 and gave the company an "underweight" rating in a research report on Tuesday, February 4th. Truist Financial boosted their target price on shares of Church & Dwight from $110.00 to $115.00 and gave the company a "buy" rating in a research note on Monday, February 3rd. Finally, Piper Sandler lowered their price target on Church & Dwight from $128.00 to $126.00 and set an "overweight" rating on the stock in a research report on Monday, February 3rd. Two equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and seven have given a buy rating to the company's stock. According to data from MarketBeat, Church & Dwight presently has an average rating of "Hold" and an average target price of $111.56.

Insider Buying and Selling at Church & Dwight

In other Church & Dwight news, EVP Maynadier Patrick D. De sold 54,510 shares of the business's stock in a transaction dated Monday, March 10th. The shares were sold at an average price of $115.98, for a total transaction of $6,322,069.80. Following the completion of the transaction, the executive vice president now directly owns 10,497 shares of the company's stock, valued at $1,217,442.06. The trade was a 83.85 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, EVP Rene Hemsey sold 11,060 shares of the business's stock in a transaction that occurred on Wednesday, March 12th. The stock was sold at an average price of $109.98, for a total value of $1,216,378.80. Following the transaction, the executive vice president now owns 6,437 shares of the company's stock, valued at approximately $707,941.26. This represents a 63.21 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 65,570 shares of company stock valued at $7,538,449 in the last three months. Corporate insiders own 2.00% of the company's stock.

Church & Dwight Profile

Church & Dwight Co, Inc engages in the development, manufacture, and marketing of household, personal care, and specialty products. It operates through the following segments: Consumer Domestic, Consumer International, Specialty Products Division (SPD), and Corporate. The Consumer Domestic segment offers household products, such as laundry detergents, fabric softener sheets, cat litter, household cleaning products, and personal care products including antiperspirants, oral care products, depilatories, reproductive health products, oral analgesics, nasal saline moisturizers, and dietary supplements.